Počet záznamů: 1
Primer Sequence Disclosure: A Clarification of the MIQE Guidelines
SYS 0364331 LBL 02258^^^^^2200397^^^450 005 20240103195532.2 014 $a 000291028600026 $2 WOS 017 70
$a 10.1373/clinchem.2011.162958 $2 DOI 100 $a 20120314d m y slo 03 ba 101 0-
$a eng $d eng 102 $a US 200 1-
$a Primer Sequence Disclosure: A Clarification of the MIQE Guidelines 215 $a 3 s. 463 -1
$1 001 cav_un_epca*0256418 $1 011 $a 0009-9147 $e 1530-8561 $1 200 1 $a Clinical Chemistry $v Roč. 57, č. 6 (2011), s. 919-921 $1 210 $c Oxford University Press 610 0-
$a real-time PCR 610 0-
$a MIQE 610 0-
$a quality 700 -1
$3 cav_un_auth*0235650 $a Bustin $b S.A. $y GB $4 070 701 -1
$3 cav_un_auth*0020418 $a Benes $b V. $y DE $4 070 701 -1
$3 cav_un_auth*0250655 $a Garson $b J.A. $y GB $4 070 701 -1
$3 cav_un_auth*0249575 $a Hellemans $b J. $y BE $4 070 701 -1
$3 cav_un_auth*0249576 $a Huggett $b J. $y GB $4 070 701 -1
$3 cav_un_auth*0239800 $a Kubista $b Mikael $i Laboratoř genové exprese $j Laboratory of Gene Expression $p BTO-N $w Development of Diagnostic and Therapeutic Procedures $4 070 $T Biotechnologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0249577 $a Mueller $b R. $y US $4 070 701 -1
$3 cav_un_auth*0274406 $a Nolan $b T. $y GB $4 070 701 -1
$3 cav_un_auth*0232536 $a Pfaffl $b M.W. $y DE $4 070 701 -1
$3 cav_un_auth*0250657 $a Shipley $b G.L. $y US $4 070 701 -1
$3 cav_un_auth*0274407 $a Vandesompele $b J. $y BE $4 070 701 -1
$3 cav_un_auth*0274408 $a Wittwer $b C.T. $y US $4 070
Počet záznamů: 1